Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2013.03.017PMID 23706946PMCID PMC3758381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).

  2013cited by this paper
• Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity.

  2012cited by this paper
• Changes of serum VEGF concentration after intravitreal injection of Avastin in treatment of diabetic retinopathy

  2012cited by this paper
• Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.

  2012cited by this paper
• Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?

  2012cited by this paper
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

  2012cited by this paper
• Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

  2012cited by this paper
• Association of ARMS2 genotype with bilateral involvement of exudative age-related macular degeneration.

  2012cited by this paper
• Age-related macular degeneration

  2012cited by this paper
• Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: 2-Year Results: Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group‡*

  2012cited by this paper
• Reproducibility of Optical Coherence Tomography Image Grading During the Comparisons of Age-Related Macular Degeneration Treatments Trials (CATT)

  2012cited by this paper
• Vascular endothelial growth factor plasma levels before and after treatment of neovascular age‐related macular degeneration with bevacizumab or ranibizumab

  2012cited by this paper
• Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials.

  2012cited by this paper
• Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration.

  2012cited by this paper
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

  2011cited by this paper
• Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file.

  2011cited by this paper
• VITREOUS AND PLASMA CONCENTRATIONS OF APELIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL BEVACIZUMAB IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY

  2011cited by this paper
• Genetics of Age-Related Macular Degeneration: Current Concepts, Future Directions

  2011cited by this paper
• Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

  2011cited by this paper
• Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.

  2011cited by this paper
• BILATERAL EFFECT OF UNILATERAL RANIBIZUMAB IN PATIENTS WITH UVEITIS-RELATED MACULAR EDEMA

  2011cited by this paper
• Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.

  2010cited by this paper
• Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.

  2010cited by this paper
• The effect of methotrexate on corneal neovascularization in rabbits.

  2010cited by this paper
• Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab

  2010cited by this paper
• Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

  2010cited by this paper
• Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema.

  2009cited by this paper
• Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

  2009cited by this paper
• Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study

  2009cited by this paper
• Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

  2007cited by this paper
• Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.

  2007cited by this paper
• Pharmacokinetics of intravitreal ranibizumab (Lucentis).

  2007cited by this paper
• PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS

  2007cited by this paper
• Pharmacokinetics of intravitreal bevacizumab (Avastin).

  2007cited by this paper
• [Age-related macular degeneration].

  2006cited by this paper
• Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

  2006cited by this paper
• A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.

  2005cited by this paper
• The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.

  2005cited by this paper
• Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.

  2005cited by this paper
• RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND VISION LOSS IN THE FELLOW EYE STUDY OF CNVPT

  2003cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye.

  1998cited by this paper
• Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.

  1997cited by this paper
• Available

  1984cited by this paper

• Nonclinical study of ixo-vec gene therapy for nAMD supports efficacy for a human dose of 6E10 vg/eye and staggered dosing of fellow eyes

  2025cites this paper
• TEN-YEAR FOLLOW-UP OF FELLOW EYES IN PATIENTS WITH UNILATERAL NAIVE EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2024cites this paper
• Importance of optical coherence tomography raster scans in early detection of active fellow-eye neovascularization in unilateral neovascular age-related macular degeneration

  2024cites this paper
• Assessment of optical coherence tomography biomarkers in patients with non-neovascular age-related macular degeneration (AMD) converting to exudative AMD according to the status of the fellow eye

  2024cites this paper
• Early detection of fellow eye involvement in exudative AMD using OdySight: A remote-monitoring mobile medical application.

  2024cites this paper
• Bilateral Involvement of Age-Related Macular Degeneration in South Korea: Findings from the Korea National Health and Nutrition Examination Survey 2017–2020

  2024cites this paper
• American Society of Retina Specialists Clinical Practice Guidelines on Multimodal Imaging for Retinal Disease

  2024cites this paper
• Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

  2023cites this paper
• Exudative Progression of Treatment-Naïve Non-Exudative Macular Neovascularization in Age-Related Macular Degeneration: A Systematic Review with Meta-Analyses.

  2023cites this paper
• The Predictive Capabilities of Artificial Intelligence-Based OCT Analysis for Age-Related Macular Degeneration Progression—A Systematic Review

  2023cites this paper
• Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration

  2023cites this paper
• Levodopa is associated with reduced development of neovascular age-related macular degeneration.

  2023cites this paper
• Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.

  2022cites this paper
• Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial.

  2021cites this paper
• Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization

  2021cites this paper
• Real-life-Ergebnisse der Anti-VEGF-Therapie bei nAMD der Partneraugen

  2021cites this paper
• A Comprehensive Review of Retinal Vascular and Optical Nerve Diseases Based on Optical Coherence Tomography Angiography

  2021cites this paper
• Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections.

  2021cites this paper
• Genetics of Age-Related Macular Degeneration in Asia

  2021cites this paper
• Current Management of Age-Related Macular Degeneration.

  2021cites this paper
• Identifying early symptoms of choroidal neovascularisation in second eyes of patients with unilateral wet age related macular degeneration using a telephone evaluation method

  2021cites this paper
• Retinal diseases diagnosis based on optical coherence tomography angiography

  2020cites this paper
• Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

  2020cites this paper
• INFLUENCE OF FELLOW-EYE EXAMINATION INTERVAL ON VISUAL ACUITY AT FELLOW-EYE NEOVASCULARIZATION IN UNILATERAL TYPE 3 NEOVASCULARIZATION.

  2020cites this paper
• Age-Related Macular Degeneration (AMD): Non-neovascular and Neovascular AMD

  2020cites this paper
• Genomics in Choroidal Neovascularization

  2020cites this paper
• Influence of unilateral intravitreal bevacizumab injection on the incidence of symptomatic choroidal neovascularization in the fellow eye in patients with neovascular age-related macular degeneration (Review)

  2020cites this paper
• Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds

  2020cites this paper
• Predicting conversion to wet age-related macular degeneration using deep learning

  2020cites this paper
• Nonexudative Macular Neovascularization - A Systematic Review of Prevalence, Natural History, and Recent Insights from OCT Angiography.

  2020cites this paper
• CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2020cites this paper
• OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.

  2019cites this paper
• Polypoidal Choroidal Vasculopathy: Outer Retinal and Choroidal Changes and Neovascularization Development in the Fellow Eye.

  2019cites this paper
• Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

  2019cites this paper
• Predictive Value of the OCT Double-Layer Sign for Identifying Subclinical Neovascularization in Age-Related Macular Degeneration.

  2019cites this paper
• Detection of Nonexudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using OCT Angiography.

  2019cites this paper
• The Moorfields AMD Database Report 2 - Fellow Eye Involvement with Neovascular Age-related Macular Degeneration

  2019cites this paper
• Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.

  2019cites this paper
• Diagnostic accuracy of optical coherence tomography angiography for choroidal neovascularization: a systematic review and meta-analysis

  2019cites this paper
• Association Between Cilioretinal Arteries and Advanced Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT).

  2019cites this paper
• Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration

  2019cites this paper
• Ophthalmika

  2019cites this paper
• Detection of Non-exudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using Optical Coherence Tomography Angiography

  2019cites this paper
• Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT Angiography

  2018cites this paper
• Radial shape discrimination testing for new-onset neovascular age-related macular degeneration in at-risk eyes

  2018cites this paper
• Intensity and polarization-sensitive optical coherence tomography features in acquired retinal diseases / submitted by Philipp K. Roberts

  2018cites this paper
• ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling

  2018cites this paper
• Spectral-Domain Optical Coherence Tomography Associations of Neovascular Conversion in Age-Related Macular Degeneration

  2018cites this paper
• Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline

  2018cites this paper
• Anti‐vascular endothelial growth factors treatment of wet age‐related macular degeneration: from neurophysiology to cost‐effectiveness

  2018cites this paper
• Machine Learning to Analyze the Prognostic Value of Current Imaging Biomarkers in Neovascular Age-Related Macular Degeneration.

  2018cites this paper
• Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye

  2018cites this paper
• Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD

  2018cites this paper
• Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome

  2017cites this paper
• Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography.

  2017cites this paper
• A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration

  2017cites this paper
• Current Best Clinical Practices—Management of Neovascular AMD

  2017cites this paper
• HTRA1 and TGF-β1 Concentrations in the Aqueous Humor of Patients With Neovascular Age-Related Macular Degeneration.

  2017cites this paper
• ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION

  2017cites this paper
• Retinal pigment epithelial features indicative of neovascular progression in age-related macular degeneration

  2017cites this paper
• Guidelines for the Management of Wet Age-Related Macular Degeneration: Recommendations from a Panel of Greek Experts

  2016cites this paper
• Pharmacogenomics of Drugs in Ocular Therapeutics

  2016cites this paper
• Age-Related Macular Degeneration and Vision Impairment

  2016cites this paper
• Visual Acuity at Presentation in the Second Eye versus First Eye in Patients with Exudative Age-Related Macular Degeneration

  2016cites this paper
• Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice

  2016cites this paper
• Cost‐effectiveness of treating wet age‐related macular degeneration at the Kuopio University Hospital in Finland based on a two‐eye Markov transition model

  2016cites this paper
• [Unilateral Ranibizumab Treatment and Reduction of Macular Edema in the Contralateral Eye. Medication Effect or Natural Course?].

  2016cites this paper
• Toward personalized medicine in age-related macular degeneration

  2016cites this paper
• Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).

  2016cites this paper
• Parenting discipline styles and child psychopathology in a sample of Egyptian children with accidental ocular trauma: a case–control study

  2016cites this paper
• OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC

  2016cites this paper
• Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

  2016cites this paper
• Optical coherence tomography, fluorescein angiography, and the management of neovascular age-related macular degeneration.

  2015cites this paper
• Dégénérescence maculaire liée à l’âge. État des lieux 2015

  2015cites this paper
• The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.

  2015cites this paper
• The Contribution of Genetic Architecture to the 10-Year Incidence of Age-Related Macular Degeneration in the Fellow Eye.

  2015cites this paper
• Age-related Macular Degeneration in Older Populations: Long-Term Incidence, Progression and Associations

  2015cites this paper
• The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes.

  2014cites this paper
• Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials

  2014cites this paper
• Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies

  2014cites this paper
• Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

  2014cites this paper
• Stem cell clinical trials: toward cell-based therapy for retinal degenerations

  2013cites this paper
• What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?

  2013cites this paper